ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 135 filers reported holding ROYALTY PHARMA PLC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,289 | -57.2% | 84 | -40.8% | 0.00% | – |
Q2 2023 | $5,342 | -78.6% | 142 | -74.6% | 0.00% | -100.0% |
Q1 2023 | $24,920 | +166033.3% | 560 | +69.2% | 0.00% | – |
Q4 2022 | $15 | -99.9% | 331 | +5.4% | 0.00% | – |
Q3 2022 | $14,000 | 0.0% | 314 | +0.6% | 0.00% | – |
Q2 2022 | $14,000 | -51.7% | 312 | -52.4% | 0.00% | – |
Q1 2022 | $29,000 | +2800.0% | 655 | +6450.0% | 0.00% | – |
Q4 2021 | $1,000 | – | 10 | – | 0.00% | – |
Q2 2021 | $0 | – | 0 | – | 0.00% | – |
Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
Q4 2020 | $2,000 | -94.4% | 38 | -95.5% | 0.00% | -100.0% |
Q3 2020 | $36,000 | +89.5% | 850 | +112.5% | 0.00% | 0.0% |
Q2 2020 | $19,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
Brown University | 621,759 | $22,470,000 | 3.05% |
Graypoint LLC | 610,584 | $22,067,000 | 2.71% |